Ellen Wright Clayton,Barbara J Evans,James W Hazel et al.
Ellen Wright Clayton et al.
Recent advances in technology have significantly improved the accuracy of genetic testing and analysis, and substantially reduced its cost, resulting in a dramatic increase in the amount of genetic information generated, analysed, shared, a...
Is it 'gene therapy'? [0.03%]
是“基因治疗”吗？
Jacob S Sherkow,Patricia J Zettler,Henry T Greely
Jacob S Sherkow
Present-day posthumous reproduction and traditional levirate marriage: two types of interactions [0.03%]
现代嗣子婚与传统交换婚：两种社会互动形式
Avishalom Westreich
Avishalom Westreich
The paper studies the position of Jewish law on posthumous reproduction and its mutual interaction with the legal and bioethical discussion of this issue. It examines two types of interactions: a direct, legal-positive interaction and a met...
Amy Zarzeczny,Harold Atkins,Judy Illes et al.
Amy Zarzeczny et al.
Neuroscience, criminal responsibility and sentencing in an islamic country: Iran [0.03%]
神经科学、刑事责任和伊斯兰国家的量刑：以伊朗为例
Armin Alimardani
Armin Alimardani
The implications of neuroscience in the legal context have been considered in many countries; however, there has been very little (if any) research on the use of neuroscience in criminal law in Iran. Furthermore, because Iran's legal system...
Genetic research and applicable law: the intra-EU conflict of laws as a regulatory challenge to cross-border genetic research [0.03%]
基因研究与可适用法律：欧盟内部法律冲突对跨境基因研究的规制挑战
Kärt Pormeister
Kärt Pormeister
EU law does not regulate genetic research per se, but the latter is governed to a certain extent by data protection law. Regardless of the harmonizing efforts of the General Data Protection Regulation (GDPR), research regulations remain fra...
Protecting essential information about genetic variants as trade secrets: a problem for public policy? [0.03%]
作为商业秘密保护基因变异的重要信息：一个公共政策问题吗？
Alexis K Juergens,Leslie P Francis
Alexis K Juergens
In 2013, the U.S. Supreme Court held that naturally occurring human genes are not patentable subject matter. This decision, invalidating patents held by Myriad Genetics involving genes affecting breast cancer, appeared to further the consti...
Addressing the needs of Canadians with rare diseases: an evaluation of orphan drug incentives [0.03%]
加拿大罕见病患者药物需求评估：孤儿药激励措施分析报告
Emily Harris
Emily Harris
It is uncertain whether a Canadian orphan drug policy, similar to those used in the US and EU, will be given further consideration. The justification for having an orphan drug policy is initially discussed, with this article proceeding on t...
Robin Feldman
Robin Feldman
Presenting the first comprehensive study of evergreening, this article examines the extent to which evergreening behavior-which can be defined as artificially extending the protection cliff-may contribute to the problem. The author analyses...
Rochelle C Dreyfuss,Jane Nielsen,Dianne Nicol
Rochelle C Dreyfuss
The landscape for patenting products and processes tied to the natural world has changed dramatically in recent times as a result of a series of decisions of the US Supreme Court, particularly Mayo Collaborative Services v Prometheus Labora...